Li X, Wang J, Liu T, Alvarez A, et al. Impact of Time of Injection on the Efficacy and Safety of iGlarLixi Versus IDegAsp in Chinese People With Type 2 Diabetes: Exploratory Analysis of the Soli-D Study. Diabetes Obes Metab 2026 May 25. doi: 10.1111/dom.70902.
PMID: 42186210